Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 30;11(7):1010.
doi: 10.3390/foods11071010.

Thinned Nectarines, an Agro-Food Waste with Antidiabetic Potential: HPLC-HESI-MS/MS Phenolic Characterization and In Vitro Evaluation of Their Beneficial Activities

Affiliations

Thinned Nectarines, an Agro-Food Waste with Antidiabetic Potential: HPLC-HESI-MS/MS Phenolic Characterization and In Vitro Evaluation of Their Beneficial Activities

Elisabetta Schiano et al. Foods. .

Abstract

Due to the side effects of synthetic drugs, the interest in the beneficial role of natural products in the management of diabetic conditions is growing over time. In the context of agro-food waste products, a screening of different fruit thinning by-products identified thinned nectarines (TN) as the richest matrices of abscisic acid (ABA), a phytohormone with well-documented hypoglycemic potential. These waste-food matrices may represent not only precious sources of ABA but also other bioactive molecules with potential health benefits, such as polyphenols. Therefore, we aimed to perform a qualitative and quantitative characterization of a polyphenolic profile of a TN-based nutraceutical formulation through HPLC-HESI-MS/MS and HPLC-DAD-FLD analyses. Additionally, the in vitro antioxidant and antidiabetic potential of TN was investigated. HPLC analyses allowed us to identify forty-eight polyphenolic compounds, nineteen of which were quantified. Moreover, the results obtained through different in vitro assays showed the antioxidant and antidiabetic potential exerted by the tested nutraceutical formulation. In conclusion, the concomitant presence of different bioactive compounds in TN-based nutraceutical formulation, such as ABA and polyphenols, would reasonably support TN as an innovative nutraceutical formulation useful for the management of glucose homeostasis. Further in-depth animal-based studies and clinical trials are needed to deepen these aspects.

Keywords: abscisic acid; agro-food waste products; bioactive compounds; glucose homeostasis; polyphenols.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Antioxidant activity of Thinned Nectarine extracts expressed as (a) EC50 of DPPH assay and (b) EC50 of ABTS assay. Values represent mean ± standard deviation of triplicate readings.
Figure 2
Figure 2
Inhibition of a-amylase activity (%) by Thinned Nectarine and acarbose. Values represent mean ± standard deviation of triplicate readings.
Figure 3
Figure 3
Inhibition of Advances Glycation End-Product formation (%) by Thinned Nectarine and rutin. Values represent mean ± standard deviation of triplicate readings.

References

    1. Sun H., Saeedi P., Karuranga S., Pinkepank M., Ogurtsova K., Duncan B.B., Stein C., Basit A., Chan J.C.N., Mbanya J.C., et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022;183:109119. doi: 10.1016/j.diabres.2021.109119. - DOI - PMC - PubMed
    1. Aschner P. New IDF clinical practice recommendations for managing type 2 diabetes in primary care. Diabetes Res. Clin. Pract. 2017;132:169–170. doi: 10.1016/j.diabres.2017.09.002. - DOI - PubMed
    1. Krass I., Schieback P., Dhippayom T. Adherence to diabetes medication: A systematic review. Diabet. Med. 2015;32:725–737. doi: 10.1111/dme.12651. - DOI - PubMed
    1. Tan S.Y., Mei Wong J.L., Sim Y.J., Wong S.S., Mohamed Elhassan S.A., Tan S.H., Ling Lim G.P., Rong Tay N.W., Annan N.C., Bhattamisra S.K., et al. Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention. Diabetes Metab. Syndr. Clin. Res. Rev. 2019;13:364–372. doi: 10.1016/j.dsx.2018.10.008. - DOI - PubMed
    1. Ota A., Ulrih N.P. An overview of herbal products and secondary metabolites used for management of type two diabetes. Front. Pharmacol. 2017;8:436. doi: 10.3389/fphar.2017.00436. - DOI - PMC - PubMed

LinkOut - more resources